About Telescope Innovations
Vancouver chemical-technology company developing self-driving laboratories, online analytical sampling tools, and scalable process-development capabilities for pharmaceutical, chemical, and critical-mineral applications.
Operating context
Telescope’s automation portfolio now has a more specific link between analytical sampling and reactor control. Its June 2026 operating update describes an AGI development agreement to integrate DirectInject-LC reaction sampling into reactor systems, and an invoiced DirectInject-IC platform for measuring critical ions during lithium-material purification. These are distinct analytical products alongside the self-driving laboratory platform. The same quarter produced C$2.12 million of revenue and an adjusted EBITA loss of C$1.06 million, reflecting commercial activity alongside continuing investment. GAC independently confirms Telescope technology in the Korean pharmaceutical association’s self-driving laboratory. The third European pharmaceutical SDL was contracted with installation expected later; the contract should not be recast as accepted deployment without a subsequent milestone.
